Patient and Caregiver Insight Into the Impact of Non-Muscle Invasive Bladder Cancer and Its Treatments: A Social Media Review

Author(s)

Crawford R1, Thompson A2, Chang J2, Morrison R3, Doward L1
1RTI-Health Solutions, Manchester, UK, 2Pfizer, Inc, New York, NY, USA, 3RTI Health Solutions, Manchester, LAN, UK

Presentation Documents

OBJECTIVES: To gain insights into patient/caregiver experience of non-muscle invasive bladder cancer (NMIBC) and its treatments (e.g., intra-vesical Bacillus Calmette-Guerin [BCG]/cystectomy) using social media (SM) data.

METHODS: Web-based searches identified SM data from 3 sources: the Fight Bladder Cancer website, YouTube, Reddit. English-language SM posts shared by adult patients or caregivers were reviewed if related to NMIBC disease and treatments. SM data were analyzed thematically.

RESULTS: Of 638 SM posts identified, 45 met the review criteria (20 videos, 13 blog/forum posts, 12 comments) and were shared by 38 contributors (31 patients; 7 caregivers). 21 (55%) contributors discussed symptoms including hematuria, urinary urgency, dysuria in relation to their NMIBC. Contributors discussed the impact NMIBC had on patients’ emotional/psychological-well-being (n=21; 55%), relationships (n=10;26%), daily life (n=7;18%), and work (n=6;16%). All 7 caregivers discussed impacts of caring for NMIBC patients: fear, stress, helplessness, low-mood, worry, feelings of loss, fatigue, and intimacy concerns. 32 (84%) contributors reported ≥1 NMIBC-related treatment experiences: cystoscopy (n=25;66%), BCG (n=23;61%), TURBT (n=21;55%), chemotherapy (n=9;24%), and cystectomy (n=8;21%). Few contributors (n=5, 13%) reported BCG treatment length which ranged from 6 weeks to 2 years. 8 (21%) contributors noted they or family member were in remission, and 5 patients noted ≥1 recurrence. 21 (55%) contributors commented on the negative impacts of treatments related to side effects, discomfort, inconveniences, work productivity, and emotional, physical and financial burdens.

CONCLUSIONS: SM data related to disease and treatment provide an opportunity for patient/caregiver voice to be heard. This research revealed their candid feedback on the burden and unmet needs of NMIBC and its treatments. Unsolicited SM posts from patients/caregivers may not be generalizable, but qualitative analysis of SM data can inform future study design to examine unmet needs and patient preferences. Guidance on SM research should be developed to increase methodology consistency across studies.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

PCR97

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×